EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

JAK3 and TEC-family kinase expression, spatial distribution and inhibition by ritlecitinib in vitiligo pathogenesis

Emma Holtappels, Alex Rooker, Wouter Ouwerkerk, Saskia Chielie, Nathalie O P van Uden, Tessa Licher, Sanne E Uitentuis, Marcel W Bekkenk, Albert Wolkerstorfer, Rosalie M Luiten, Walbert J Bakker

Journal of Investigative Dermatology · 2026-11

DOI: 10.1016/j.jid.2026.10.045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-11. Verfasst von Emma Holtappels und 10 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam University Medical Center, Department of Dermatology, Netherlands Institute for Pigment Disorders, University of Amsterdam, Amsterdam insti…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Global Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

JAK3Non-segmental vitiligoTEC-kinasesmultiplex immunohistochemistryritlecitinib

Autor:innen und Institutionen

  • Amsterdam University Medical Center, Department of Dermatology, Netherlands Institute for Pigment Disorders, University of Amsterdam, Amsterdam institute for Immunology and Infectious diseases, the Netherlands.
  • Amsterdam University Medical Center, Department of Dermatology, Netherlands Institute for Pigment Disorders, University of Amsterdam, Amsterdam institute for Immunology and Infectious diseases, the Netherlands; National…
  • Amsterdam University Medical Center, Department of Dermatology, Netherlands Institute for Pigment Disorders, University of Amsterdam, Amsterdam institute for Immunology and Infectious diseases, the Netherlands; VU Unive…
  • Amsterdam University Medical Center, Department of Dermatology, Netherlands Institute for Pigment Disorders, University of Amsterdam, Amsterdam institute for Immunology and Infectious diseases, the Netherlands. Electron…

Förderung

  • Pfizer Global Pharmaceuticals

Zitieren

APA

Holtappels, E., Rooker, A., Ouwerkerk, W., Chielie, S., van Uden, N. O. P., Licher, T., Uitentuis, S. E., Bekkenk, M. W., Wolkerstorfer, A., Luiten, R. M., & Bakker, W. J. (2026). JAK3 and TEC-family kinase expression, spatial distribution and inhibition by ritlecitinib in vitiligo pathogenesis. Journal of Investigative Dermatology. https://doi.org/10.1016/j.jid.2026.10.045

Vancouver

Holtappels E, Rooker A, Ouwerkerk W, Chielie S, van Uden NOP, Licher T, et al. JAK3 and TEC-family kinase expression, spatial distribution and inhibition by ritlecitinib in vitiligo pathogenesis. Journal of Investigative Dermatology. 2026. doi:10.1016/j.jid.2026.10.045

BibTeX
@article{Holtappels2026,
  author = {Holtappels, Emma and Rooker, Alex and Ouwerkerk, Wouter and Chielie, Saskia and van Uden, Nathalie O P and Licher, Tessa and Uitentuis, Sanne E and Bekkenk, Marcel W and Wolkerstorfer, Albert and Luiten, Rosalie M and Bakker, Walbert J},
  title = {JAK3 and TEC-family kinase expression, spatial distribution and inhibition by ritlecitinib in vitiligo pathogenesis},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  doi = {10.1016/j.jid.2026.10.045}
}
Kostenlos starten →